2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole
Structure Info
- Chemspace ID
- CSSB00000688913 (In-Stock Building Blocks)
- CAS
- 1313049-30-7
- MFCD
- MFCD22392054, MFCD22392054
- IUPAC Name
- 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole
- Mol formula
- C15H19BN2O2
- Mol weight
- 270 Da
- Catalog Number(s)
- 314110, A069003585, A482891, AA01A0AR, ACNPQH948, AD254891, AG-B38474, AG01A0DJ, AR01A12J, AT32555, AV46463, BB4LS-EN300-109654, BBLS00000688913, BBV-40436618, BD00734155, BD46463, CS-0231725, CS-29317, CSC000688913, EC01A2JB, EN300-109654, H12099E, HY-W170576, LN04816250, NCC04930, OR1073032, ST01A1UB, TX01A1J7, Y3173067, Y4269762, Z1425690619, Z2009985933, a6_29343_2427, bbls00000688913
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.8
- Heavy atoms count
- 20
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.4
- Polar surface area (Å)
- 47
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB00000688913
Items Overall 92 items from 25 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 95 | 100 mg | 157.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 95 | 250 mg | 259.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 95 | 1 g | 659.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 95 | 5 g | 1,841.00 | |
Description: Name:2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| BLD Pharmatech GmbH | 1 day | Germany To: | 95 | 100 mg | 157.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 95 | 250 mg | 259.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 95 | 1 g | 659.00 | |
Description: Name:2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| BLD PHARMATECH LTD CN | 1 day | China To: | 95 | 100 mg | 157.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 95 | 250 mg | 259.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 95 | 1 g | 659.00 | |
| BLD PHARMATECH LTD CN | 1 day | China To: | 95 | 5 g | 1,841.00 | |
Description: Name:2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 116.42 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 159.06 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 216.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 278.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 344.00 | |
| Astatech CN | 2 days | China To: | 95 | 100 mg | 163.90 | |
| Astatech CN | 2 days | China To: | 95 | 250 mg | 304.70 | |
| Astatech CN | 2 days | China To: | 95 | 1 g | 799.70 | |
Description: (3-(1H-IMIDAZOL-2-YL)PHENYL)BORONIC ACID PINACOL ESTER; CAS: 1313049-30-7 | ||||||
| Astatech Inc | 2 days | United States To: | 95 | 100 mg | 163.90 | |
| Astatech Inc | 2 days | United States To: | 95 | 250 mg | 304.70 | |
| Astatech Inc | 2 days | United States To: | 95 | 1 g | 799.70 | |
Description: (3-(1H-IMIDAZOL-2-YL)PHENYL)BORONIC ACID PINACOL ESTER; CAS: 1313049-30-7 | ||||||
| Enamine US, Inc. | 2 days | United States To: | 95 | 50 mg | 205.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 100 mg | 304.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 250 mg | 434.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 500 mg | 684.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 1 g | 877.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 2.5 g | 1,468.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 5 g | 2,452.00 | |
| 1st Scientific LLC | 3 days | United States To: | 95 | 100 mg | 140.80 | |
| 1st Scientific LLC | 3 days | United States To: | 95 | 250 mg | 232.10 | |
| 1st Scientific LLC | 3 days | United States To: | 95 | 1 g | 588.50 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| Matrix Scientific | 3 days | United States To: | 95 | 1 g | 745.80 | |
Description: Name: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 116.42 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 159.06 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 216.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 278.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 344.00 | |
| Angene International Limited | 10 days | China To: | 95 | 100 mg | 143.10 | |
| Angene International Limited | 10 days | China To: | 95 | 250 mg | 225.90 | |
| Angene International Limited | 10 days | China To: | 95 | 1 g | 584.10 | |
| Angene International Limited | 10 days | China To: | 95 | 5 g | 1,630.80 | |
Description: 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| AiFChem CN | 10 days | China To: | 95 | 100 mg | 149.00 | |
| AiFChem CN | 10 days | China To: | 95 | 250 mg | 246.00 | |
| AiFChem CN | 10 days | China To: | 95 | 1 g | 626.00 | |
| AiFChem CN | 10 days | China To: | 95 | 5 g | 1,748.00 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; Hazard statement: H302, H312, H332; CAS: 1313049-30-7 | ||||||
| Advanced ChemBlocks CN | 10 days | China To: | 95 | 250 mg | 305.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 95 | 1 g | 785.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 95 | 5 g | 3,140.00 | |
Description: 2-[3-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole; CAS: 1313049-30-7 | ||||||
| Angel Pharmatech Ltd. | 10 days | China To: | 95 | 500 mg | 470.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 95 | 1 g | 720.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 95 | 5 g | 1,900.00 | |
Description: CAS: 1313049-30-7,56503-49-2 | ||||||
| Ambeed CN | 12 days | China To: | 95 | 100 mg | 141.30 | |
| Ambeed CN | 12 days | China To: | 95 | 250 mg | 233.10 | |
| Ambeed CN | 12 days | China To: | 95 | 1 g | 593.10 | |
| Ambeed CN | 12 days | China To: | 95 | 5 g | 1,656.90 | |
Description: Name: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| Ambeed GmbH | 12 days | Germany To: | 95 | 100 mg | 141.30 | |
| Ambeed GmbH | 12 days | Germany To: | 95 | 250 mg | 233.10 | |
| Ambeed GmbH | 12 days | Germany To: | 95 | 1 g | 593.10 | |
Description: Name: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 95 | 100 mg | 141.30 | |
| Ambeed, Inc. | 12 days | United States To: | 95 | 250 mg | 233.10 | |
| Ambeed, Inc. | 12 days | United States To: | 95 | 1 g | 593.10 | |
| Ambeed, Inc. | 12 days | United States To: | 95 | 5 g | 1,656.90 | |
Description: Name: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| AA BLOCKS | 12 days | United States To: | 95 | 100 mg | 151.80 | |
| AA BLOCKS | 12 days | United States To: | 95 | 250 mg | 250.80 | |
| AA BLOCKS | 12 days | United States To: | 95 | 1 g | 636.90 | |
| AA BLOCKS | 12 days | United States To: | 95 | 5 g | 1,777.60 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)-1H-Imidazole; CAS: 1313049-30-7 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 100 mg | 165.60 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 250 mg | 262.20 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 1 g | 681.95 | |
| A2B Chem | 12 days | United States To: | 95 | 100 mg | 200.10 | |
| A2B Chem | 12 days | United States To: | 95 | 250 mg | 331.20 | |
| A2B Chem | 12 days | United States To: | 95 | 1 g | 841.80 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| Anichem, Inc | 12 days | United States To: | 90 | 1 g | 539.00 | |
| Anichem, Inc | 12 days | United States To: | 90 | 5 g | 1,595.00 | |
Description: 2-[3-(TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]-1H-IMIDAZOLE; CAS: 1313049-30-7 | ||||||
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 205.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 304.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 434.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 684.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 877.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,468.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,452.00 | |
| eNovation CN | 20 days | China To: | 95 | 100 mg | 143.75 | |
| eNovation CN | 20 days | China To: | 95 | 250 mg | 212.75 | |
| eNovation CN | 20 days | China To: | 95 | 1 g | 523.25 | |
| eNovation CN | 20 days | China To: | 95 | 5 g | 1,466.25 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 95 | 100 mg | 161.70 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 250 mg | 255.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 1 g | 656.70 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
| 10X CHEM | TBD | United States To: | 95 | 100 mg | 140.80 | |
| 10X CHEM | TBD | United States To: | 95 | 250 mg | 233.20 | |
| 10X CHEM | TBD | United States To: | 95 | 1 g | 590.70 | |
Description: 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole; CAS: 1313049-30-7 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of ethyl 4-methyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole-5-carboxylate - CSSB02516459729](/st/structure/200/cab46f1fb29fa099ce5547d5ce68070e/CCOC%2528%253DO%2529C1%253DC%2528C%2529N%253DC%2528N1%2529C1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 1-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,3-benzodiazole - CSSB00020632260](/st/structure/200/7799c6114932bff38833f18b6fecf0ca/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2N1C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 1-phenyl-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]imidazo[1,5-a]pyridine - CSSB03437846780](/st/structure/200/9da8129fb277d355cabfb456beab1b9b/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%2528%253DC2C%253DCC%253DCN12%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 1-phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-phenanthro[9,10-d]imidazole - CSSB21044590337](/st/structure/200/79221889cccf272af96c32c17193da42/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC2%253DC%2528N1C1%253DCC%253DCC%253DC1%2529C1%253DC%2528C%253DCC%253DC1%2529C1%253DC2C%253DCC%253DC1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole - CSSB00010144312](/st/structure/200/3acbc186ae614d820b5cedf82a8e1280/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%253DCN1.png)
![Chemical structure of 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4H-1,2,4-triazole - CSSB00021308312](/st/structure/200/1dac802b638bb4826404a11e5b9b0f4b/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DCN1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB00010365631](/st/structure/200/2a3b8b46e31bdb18ac6f78e33933976f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%253DCS1.png)
![Chemical structure of 5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2-oxazole - CSSB00010082544](/st/structure/200/da54fec9df87cb6c72c0f7e03a5c0678/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DCC%253DNO1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole - CSSB00010082543](/st/structure/200/29f6e0136a0a0e60951312cfcbefdbd9/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%253DCO1.png)
![Chemical structure of 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2-oxazole - CSSB06584797241](/st/structure/200/92b2ba1490d6c90aef6f0fcf14cc6372/CC1%2528C%2529OB%2528C2%253DCC%2528C3%253DNOC%253DC3%2529%253DCC%253DC2%2529OC1%2528C%2529C.png)
![Chemical structure of 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrazole - CSSB00011102638](/st/structure/200/c13bd3d6206f6ee047f6cafc218d7797/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNNC%253DC1.png)
